川芎嗪治疗组治疗后纤维蛋白原、血小板聚集率明显降低，而常规治疗组治疗后两者无变化；
The fibrinogen levels and platelet aggregation ratio were markedly lower in the post-treatment plasma than in the pre-treatment plasma with TMPZ.
结果：二甲基亚砜组血小板粘附率、聚集功能和低渗反应回复率均较对照组和洗涤血小板组降低。
RESULTS: in the DMSO group, platelet adherence rate, aggregating function, and recovery rate from hypotonic shack decreased during storage comparing with control and washed platelet groups.
偏头痛患者血小板聚集率在不同病程及不同型偏头痛组间无显著差异（P>0.05）。
No difference in mean CPAR between various course groups and type groups of migraineurs (P>0.05) was observed.
观察两组治疗后止血疗效及血小板聚集恢复率。
The therapeutic effect and the recovery rat of platelet aggregation in the two groups were observed.
结果对照组第12周末较治疗前全血粘度、红细胞压积显著降低，培达组第6周末较治疗前血小板聚集率、全血粘度、纤维蛋白原、红细胞压积即有显著降低，第12周末能维持此疗效。
In the end of 6 weeks, platelet aggregability, blood viscosity, fibrinogen and HCT were prominently lower than in before therapy. It could maintain the therapy efficacy in the end of 12 weeks.
麦贞花颗粒组血GMP 140、血小板最大聚集率、D 二聚体的各项指标较治疗前均有明显下降，且优于对照组（P <0 .0 5 ，P <0 .0 1）。
The various indexes of blood GMP-140, maximum aggregation rate of blood platelet and D-dimer dropped markedly, with great difference from the control group (P<0.05, P<0.01).
结果碘仿混合物组较对照全血凝时间明显缩短、血小板聚集率增大（P< 0 0 5 ） ；
Results Coagulation time was significantly shorter and congregating rate higher in IMB group than in CG group (P<0.05).
前瞻性血小板聚集率测定试验：对照组和联用组临床基线资料无显著差异。
There were no significant differs in the baseline level or 72h value after PCI of the maximum platelet aggregation rate (MPAR) between the two groups.
前瞻性血小板聚集率测定试验：对照组和联用组临床基线资料无显著差异。
There were no significant differs in the baseline level or 72h value after PCI of the maximum platelet aggregation rate (MPAR) between the two groups.
应用推荐